,
Cadilhac, Dominique A. http://orcid.org/0000-0001-8162-682X
Andrew, Nadine E.
Busingye, Doreen
Cameron, Jan
Thrift, Amanda G.
Purvis, Tara
Li, Jonathan C.
Kneebone, Ian
Thijs, Vincent
Hackett, Maree L.
Lannin, Natasha A.
Kilkenny, Monique F.
Funding for this research was provided by:
Monash University (SG516-0431)
Article History
Received: 14 April 2020
Accepted: 16 October 2020
First Online: 7 November 2020
Ethics approval and consent to participate
: The Monash University Human Research Ethics committee (CF16/1920 - 2016000979) approved the study, and all participants provided written informed consent before data collection began. A post-recruitment amendment was submitted to the Monash University Human Research Ethics Committee (#7619) to approve the collection of de-identified variables from the AuSCR on non-responders (8 March 2018).
: All authors have consented to the publication of this research as presented in this manuscript.
: DAC reports grants from the National Health and Medical Research Council (NHMRC, Australia) outside the submitted work and has received educational grants paid to her institution from Boehringer Ingelheim, Shire, Medtronic and Amgen unrelated to this project. DAC is the Data Custodian for the Australian Stroke Clinical Registry (AuSCR); NAL reports grants from NHMRC, Australia, outside the submitted work and is Chair of the Management Committee of the AuSCR; MFK reports grants from NHMRC outside the submitted work and is a member of the AuSCR Management Committee; AGT reports grants from NHMRC, Australia, outside the submitted work and is a member of the AuSCR Steering Committee. MLH reports grants from the NHMRC, during the conduct of the study. VT reports personal fees from Boehringer Ingelheim, personal fees from Pfizer/BMS, personal fees from Medtronic, personal fees from Bayer, personal fees from Amgen and personal fees from Allergan, outside the submitted work.